Activation of bioluminescene by structural complementation
US-11493504-B2 · Nov 8, 2022 · US
US12366572B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12366572-B2 |
| Application number | US-202418890453-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2024 |
| Priority date | Mar 15, 2013 |
| Publication date | Jul 22, 2025 |
| Grant date | Jul 22, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.
Opening claim text (preview).
The invention claimed is: 1. A composition comprising: (a) a polypeptide comprising SEQ ID NO: 1270; (b) a first peptide comprising an amino acid sequence having 100% sequence identity with SEQ ID NO: 2587, wherein the first peptide is conjugated to a first binding moiety; and (c) a second peptide comprising an amino acid sequence having 100% sequence identity with SEQ ID NO: 374, wherein the second peptide is conjugated to a second binding moiety. 2. The composition of claim 1 , wherein the first and second binding moieties are antibodies or antibody fragments. 3. The composition of claim 2 , wherein the first and second binding moieties are monoclonal antibodies (mAb) or single-chain variable fragments (scFvs). 4. The composition of claim 3 , wherein the first and second binding moieties recognize different epitopes on a target molecule. 5. A method of detecting a target molecule in a sample comprising: (a) contacting the sample with the composition of claim 4 and a furimazine substrate; and (b) detecting luminescence produced by a complex formed from the first peptide, the second peptide, and the polypeptide; wherein the amount of luminescence is directly proportional to the target concentration in the test sample.
Peptides, e.g. proteins {, carriers being peptides, polyamino acids, proteins} · CPC title
Services making use of location information · CPC title
Recommending goods or services · CPC title
Price estimation or determination · CPC title
for the management of goods or merchandise · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.